30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Lifecore Biomedical Inc (LFCR)

Track

The most recent insider trading activity occurred on May 28, 2025, with significant sell transactions by Aron R. English totaling over $1 million. Prior to this, multiple sell transactions by the same insider were recorded in early May 2025. The last reported buy transaction was on January 8, 2025, by Chief Executive Officer Paul Josephs.
Stock chart
Ticker: LFCR Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
English Aron R.
1 sale — total 1,071,555 USD
Sale 28 May 2025
Value US$980,715.01 | Price 167.74 | Shares 17,854
Sale 27 May 2025
Value US$692,445.24 | Price 72.32 | Shares 56,144
Sale 23 May 2025
Value US$649,386.21 | Price 6.75 | Shares 96,137
Sale 13 May 2025
Value US$86,352.80 | Price 7.00 | Shares 12,334
Sale 12 May 2025
Value US$321,426.02 | Price 7.03 | Shares 45,698
Sale 9 May 2025
Value US$4,900.00 | Price 7.00 | Shares 700
Sale 8 May 2025
Value US$35,693.14 | Price 7.00 | Shares 5,098
Sale 7 May 2025
Value US$111,098.56 | Price 7.01 | Shares 15,847
Sale 6 May 2025
Value US$4,940.09 | Price 7.05 | Shares 701
Sale 5 May 2025
Value US$173,830.71 | Price 7.08 | Shares 24,543
Buy 8 Jan 2025
Value US$97,580.00 | Price 5.74 | Shares 17,000
Proposed sale 20 Nov 2024
Value US$71,691.00 | Price 7.17 | Shares 10,000
Proposed sale 11 Nov 2024
Value US$205,803.23 | Price 6.64 | Shares 30,990
Proposed sale 31 Oct 2024
Value US$232,888.31 | Price 5.68 | Shares 40,989
Proposed sale 7 Oct 2024
Value US$65,482.00 | Price 5.19 | Shares 12,617
Buy 3 Oct 2024
Value US$695,987.30 | Price 4.10 | Shares 169,753
Buy 3 Oct 2024
Value US$504,013.00 | Price 4.10 | Shares 122,930
Buy 3 Oct 2024
Value US$623,618.20 | Price 4.10 | Shares 152,102
Buy 3 Oct 2024
Value US$5,376,379.20 | Price 4.10 | Shares 1,311,312
Proposed sale 20 Sep 2024
Value US$82,350.00 | Price 5.49 | Shares 15,000
Buy 25 Nov 2022
Value US$2,251,413.42 | Price 7.97 | Shares 282,486
Buy 25 Nov 2022
Value US$2,751,722.20 | Price 7.97 | Shares 345,260
Buy 25 Nov 2022
Value US$2,251,413.42 | Price 7.97 | Shares 282,486
Buy 25 Nov 2022
Value US$2,751,722.20 | Price 7.97 | Shares 345,260
Buy 24 Oct 2022
Value US$1,189,230.00 | Price 8.09 | Shares 147,000
Buy 24 Oct 2022
Value US$833,270.00 | Price 8.09 | Shares 103,000
Buy 13 Jan 2022
Value US$237,690.00 | Price 10.43 | Shares 22,800
Buy 13 Jan 2022
Value US$152,205.00 | Price 10.43 | Shares 14,600
Buy 13 Jan 2022
Value US$317,144.40 | Price 10.41 | Shares 30,480
Buy 13 Jan 2022
Value US$203,105.60 | Price 10.41 | Shares 19,520
Buy 12 Jan 2022
Value US$2,184,137.90 | Price 10.41 | Shares 209,872
Buy 12 Jan 2022
Value US$937,962.10 | Price 10.41 | Shares 90,128
Buy 12 Jan 2022
Value US$20,820.00 | Price 10.41 | Shares 2,000
Buy 12 Jan 2022
Value US$83,120.00 | Price 10.39 | Shares 8,000
Buy 20 Apr 2021
Value US$112,600.00 | Price 11.26 | Shares 10,000
Buy 19 Apr 2021
Value US$22,100.00 | Price 11.05 | Shares 2,000
Buy 15 Apr 2021
Value US$21,960.00 | Price 10.98 | Shares 2,000
Buy 14 Apr 2021
Value US$106,200.00 | Price 10.62 | Shares 10,000
Buy 14 Apr 2021
Value US$95,490.00 | Price 10.61 | Shares 9,000
Buy 13 Apr 2021
Value US$20,360.00 | Price 10.18 | Shares 2,000
Buy 12 Apr 2021
Value US$50,399.55 | Price 9.99 | Shares 5,045
Buy 11 Feb 2021
Value US$16,632.00 | Price 11.88 | Shares 1,400
Buy 10 Feb 2021
Value US$23,280.00 | Price 11.64 | Shares 2,000
Buy 9 Feb 2021
Value US$24,120.00 | Price 12.06 | Shares 2,000
Buy 8 Feb 2021
Value US$21,940.00 | Price 10.97 | Shares 2,000
Buy 5 Feb 2021
Value US$21,740.00 | Price 10.87 | Shares 2,000
Buy 19 Jan 2021
Value US$109,800.00 | Price 10.98 | Shares 10,000
Buy 12 Jan 2021
Value US$146,064.00 | Price 10.74 | Shares 13,600
Buy 11 Jan 2021
Value US$69,184.00 | Price 10.81 | Shares 6,400
Buy 14 Oct 2020
Value US$89,144.16 | Price 10.32 | Shares 8,638
Buy 13 Oct 2020
Value US$13,878.78 | Price 10.19 | Shares 1,362
Buy 11 May 2020
Value US$54,000.00 | Price 10.80 | Shares 5,000
Buy 6 Nov 2019
Value US$9,273.50 | Price 10.91 | Shares 850
Buy 5 Nov 2019
Value US$40,622.00 | Price 10.69 | Shares 3,800
Buy 5 Nov 2019
Value US$103,800.00 | Price 10.38 | Shares 10,000
Buy 31 Oct 2019
Value US$49,674.00 | Price 9.74 | Shares 5,100
Buy 14 Oct 2019
Value US$46,600.00 | Price 9.32 | Shares 5,000
Buy 10 Oct 2019
Value US$48,350.00 | Price 9.67 | Shares 5,000
Buy 8 Oct 2019
Value US$99,600.00 | Price 9.96 | Shares 10,000
Buy 7 Oct 2019
Value US$81,120.00 | Price 10.14 | Shares 8,000
Buy 4 Oct 2019
Value US$72,800.00 | Price 10.40 | Shares 7,000
Buy 5 Aug 2019
Value US$105,000.00 | Price 10.50 | Shares 10,000
Buy 2 Aug 2019
Value US$214,400.00 | Price 10.72 | Shares 20,000
Buy 10 Apr 2019
Value US$309,900.00 | Price 10.33 | Shares 30,000
Buy 9 Apr 2019
Value US$102,400.00 | Price 10.24 | Shares 10,000
Buy 8 Apr 2019
Value US$207,600.00 | Price 10.38 | Shares 20,000
Buy 8 Feb 2019
Value US$60,750.00 | Price 12.15 | Shares 5,000
Buy 7 Feb 2019
Value US$95,590.00 | Price 12.10 | Shares 7,900
Buy 6 Feb 2019
Value US$247,600.00 | Price 12.38 | Shares 20,000
Buy 11 Jan 2019
Value US$6,100.50 | Price 11.62 | Shares 525
Buy 10 Jan 2019
Value US$226,600.00 | Price 11.33 | Shares 20,000
Buy 10 Jan 2019
Value US$11,230.00 | Price 11.23 | Shares 1,000
Buy 8 Jan 2019
Value US$51,030.00 | Price 11.34 | Shares 4,500
Buy 8 Jan 2019
Value US$224,800.00 | Price 11.24 | Shares 20,000
Buy 8 Jan 2019
Value US$281,250.00 | Price 11.25 | Shares 25,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-28 2025-05-28 S Sale
3.7
English Aron R.
Large shareholder
17,854 +0.8%
167.74
US$980,715 		17,854 +0.8% 167.74 US$980,715
2025-05-28 2025-05-27 S Sale
3.7
English Aron R.
Large shareholder
56,144 -26.6%
72.32
US$692,445 		56,144 -26.6% 72.32 US$692,445
2025-05-28 2025-05-23 S Sale
3.7
English Aron R.
Large shareholder
22,146 +19.5%
206.64
US$4,269,759 		22,146 +19.5% 206.64 US$4,269,759
2025-05-16 2025-05-13 S Sale
3.7
English Aron R.
Large shareholder
12,334 -0.7%
7.00
US$86,353 		12,334 -0.7% 7.00 US$86,353
2025-05-12 2025-05-12 S Sale
3.7
English Aron R.
Large shareholder
45,698 -2.7%
7.03
US$321,426 		45,698 -2.7% 7.03 US$321,426
2025-05-12 2025-05-09 S Sale
3.7
English Aron R.
Large shareholder
700 -0.0%
7.00
US$4,900 		700 -0.0% 7.00 US$4,900
2025-05-12 2025-05-08 S Sale
3.7
English Aron R.
Large shareholder
5,098 -0.3%
7.00
US$35,693 		5,098 -0.3% 7.00 US$35,693
2025-05-07 2025-05-07 S Sale
3.7
English Aron R.
Large shareholder
15,847 -0.9%
7.01
US$111,099 		15,847 -0.9% 7.01 US$111,099
2025-05-07 2025-05-06 S Sale
3.7
English Aron R.
Large shareholder
701 -0.0%
7.05
US$4,940 		701 -0.0% 7.05 US$4,940
2025-05-07 2025-05-05 S Sale
3.7
English Aron R.
Large shareholder
24,543 -1.4%
7.08
US$173,831 		24,543 -1.4% 7.08 US$173,831
2025-01-08 2025-01-08 B Purchase
2.3
Josephs Paul

Chief Executive Officer

Executive Director
17,000 +3.1%
5.74
US$97,580 		17,000 +3.1% 5.74 US$97,580
2024-11-20 2024-11-20 PrS Proposed sale
3.2
Morberg John D

Former officer

Officer
10,000
7.17
US$71,691 		10,000 7.17 US$71,691
2024-11-12 2024-11-11 PrS Proposed sale
3.2
Morberg John D

Former officer

Officer
30,990
6.64
US$205,803 		30,990 6.64 US$205,803
2024-10-31 2024-10-31 PrS Proposed sale
3.2
Morberg John D

Former officer

Officer
40,989
5.68
US$232,888 		40,989 5.68 US$232,888
2024-10-07 2024-10-07 PrS Proposed sale
3.2
Morberg John D

Former officer

Officer
12,617
5.19
US$65,482 		12,617 5.19 US$65,482
2024-10-07 2024-10-03 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
169,753 +7.0%
4.10
US$695,987 		169,753 +7.0% 4.10 US$695,987
2024-10-07 2024-10-03 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
122,930 +6.2%
4.10
US$504,013 		122,930 +6.2% 4.10 US$504,013
2024-10-07 2024-10-03 B Purchase
Kiper Christopher S
Non-Executive Director Large shareholder
152,102 +91.0%
4.10
US$623,618 		152,102 +91.0% 4.10 US$623,618
2024-10-07 2024-10-03 B Purchase
Kiper Christopher S
Non-Executive Director Large shareholder
1,311,312 +47.3%
4.10
US$5,376,379 		1,311,312 +47.3% 4.10 US$5,376,379
2024-09-20 2024-09-20 PrS Proposed sale
3.2
Morberg John D

Former officer

Officer
15,000
5.49
US$82,350 		15,000 5.49 US$82,350
2023-01-18 2022-11-25 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
282,486 +13.1%
7.97
US$2,251,413 		282,486 +13.1% 7.97 US$2,251,413
2023-01-18 2022-11-25 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
345,260 +21.2%
7.97
US$2,751,722 		345,260 +21.2% 7.97 US$2,751,722
2022-11-29 2022-11-25 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
282,486 +13.1%
7.97
US$2,251,413 		282,486 +13.1% 7.97 US$2,251,413
2022-11-29 2022-11-25 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
345,260 +21.2%
7.97
US$2,751,722 		345,260 +21.2% 7.97 US$2,751,722
2022-10-26 2022-10-24 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
147,000 +7.3%
8.09
US$1,189,230 		147,000 +7.3% 8.09 US$1,189,230
2022-10-26 2022-10-24 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
103,000 +6.8%
8.09
US$833,270 		103,000 +6.8% 8.09 US$833,270
2022-01-14 2022-01-13 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
22,800 +1.1%
10.43
US$237,690 		22,800 +1.1% 10.43 US$237,690
2022-01-14 2022-01-13 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
14,600 +1.0%
10.43
US$152,205 		14,600 +1.0% 10.43 US$152,205
2022-01-14 2022-01-13 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
30,480 +1.6%
10.41
US$317,144 		30,480 +1.6% 10.41 US$317,144
2022-01-14 2022-01-13 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
19,520 +1.3%
10.41
US$203,106 		19,520 +1.3% 10.41 US$203,106
2022-01-14 2022-01-12 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
209,872 +12.0%
10.41
US$2,184,138 		209,872 +12.0% 10.41 US$2,184,138
2022-01-14 2022-01-12 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
90,128 +6.4%
10.41
US$937,962 		90,128 +6.4% 10.41 US$937,962
2022-01-14 2022-01-12 B Purchase
3.6
Schechter Joshua
Non-Executive Director
2,000 +inf%
10.41
US$20,820 		2,000 +inf% 10.41 US$20,820
2022-01-14 2022-01-12 B Purchase
3.6
Schechter Joshua
Non-Executive Director
8,000 +148.2%
10.39
US$83,120 		8,000 +148.2% 10.39 US$83,120
2021-04-22 2021-04-20 B Purchase
3.8
Walsh Patrick D
Non-Executive Director
10,000 +33.3%
11.26
US$112,600 		10,000 +33.3% 11.26 US$112,600
2021-04-20 2021-04-19 B Purchase
3.2
Morberg John D

Chief Financial Officer

Officer
2,000 +11.5%
11.05
US$22,100 		2,000 +11.5% 11.05 US$22,100
2021-04-16 2021-04-15 B Purchase
3.2
Morberg John D

Chief Financial Officer

Officer
2,000 +14.9%
10.98
US$21,960 		2,000 +14.9% 10.98 US$21,960
2021-04-15 2021-04-14 B Purchase
2.9
Hall James G

Vice President

Officer
10,000 +34.3%
10.62
US$106,200 		10,000 +34.3% 10.62 US$106,200
2021-04-15 2021-04-14 B Purchase
2.3
Bolles Albert D.

Chief Executive Officer

Officer
9,000 +24.9%
10.61
US$95,490 		9,000 +24.9% 10.61 US$95,490
2021-04-13 2021-04-13 B Purchase
3.2
Morberg John D

Chief Financial Officer

Officer
2,000 +21.3%
10.18
US$20,360 		2,000 +21.3% 10.18 US$20,360
2021-04-21 2021-04-12 B Purchase
3.6
Burgess Timothy P

Senior VP of Supply Chain

Officer
5,045 +98.9%
9.99
US$50,400 		5,045 +98.9% 9.99 US$50,400
2021-02-12 2021-02-11 B Purchase
3.2
Morberg John D

Chief Financial Officer

Officer
1,400 +17.5%
11.88
US$16,632 		1,400 +17.5% 11.88 US$16,632
2021-02-11 2021-02-10 B Purchase
3.2
Morberg John D

Chief Financial Officer

Officer
2,000 +33.3%
11.64
US$23,280 		2,000 +33.3% 11.64 US$23,280
2021-02-10 2021-02-09 B Purchase
3.2
Morberg John D

Chief Financial Officer

Officer
2,000 +50.0%
12.06
US$24,120 		2,000 +50.0% 12.06 US$24,120
2021-02-09 2021-02-08 B Purchase
3.2
Morberg John D

Chief Financial Officer

Officer
2,000 +100.0%
10.97
US$21,940 		2,000 +100.0% 10.97 US$21,940
2021-02-08 2021-02-05 B Purchase
3.2
Morberg John D

Chief Financial Officer

Officer
2,000 +inf%
10.87
US$21,740 		2,000 +inf% 10.87 US$21,740
2021-01-19 2021-01-19 B Purchase
2.3
Bolles Albert D.

Chief Executive Officer

Officer
10,000 +38.2%
10.98
US$109,800 		10,000 +38.2% 10.98 US$109,800
2021-01-13 2021-01-12 B Purchase
3.6
OBUS NELSON
Non-Executive Director
13,600 +0.5%
10.74
US$146,064 		13,600 +0.5% 10.74 US$146,064
2021-01-13 2021-01-11 B Purchase
3.6
OBUS NELSON
Non-Executive Director
6,400 +0.2%
10.81
US$69,184 		6,400 +0.2% 10.81 US$69,184
2020-10-15 2020-10-14 B Purchase
3.6
OBUS NELSON
Non-Executive Director
8,638 +0.3%
10.32
US$89,144 		8,638 +0.3% 10.32 US$89,144
2020-10-15 2020-10-13 B Purchase
3.6
OBUS NELSON
Non-Executive Director
1,362 +0.0%
10.19
US$13,879 		1,362 +0.0% 10.19 US$13,879
2020-05-12 2020-05-11 B Purchase
3.6
OBUS NELSON
Non-Executive Director
5,000 +0.2%
10.80
US$54,000 		5,000 +0.2% 10.80 US$54,000
2019-11-06 2019-11-06 B Purchase Bolles Albert D.

Chief Executive Officer

Officer
850 +3.4%
10.91
US$9,274 		850 +3.4% 10.91 US$9,274
2019-11-06 2019-11-05 B Purchase Bolles Albert D.

Chief Executive Officer

Officer
3,800 +17.7%
10.69
US$40,622 		3,800 +17.7% 10.69 US$40,622
2019-11-05 2019-11-05 B Purchase
3.6
OBUS NELSON
10,000 +0.3%
10.38
US$103,800 		10,000 +0.3% 10.38 US$103,800
2019-11-01 2019-10-31 B Purchase
3.6
Burgess Timothy P

Senior VP of Supply Chain
5,100 +inf%
9.74
US$49,674 		5,100 +inf% 9.74 US$49,674
2019-10-16 2019-10-14 B Purchase
3.6
OBUS NELSON
5,000 +0.2%
9.32
US$46,600 		5,000 +0.2% 9.32 US$46,600
2019-10-11 2019-10-10 B Purchase
3.6
OBUS NELSON
5,000 +0.2%
9.67
US$48,350 		5,000 +0.2% 9.67 US$48,350
2019-10-10 2019-10-08 B Purchase
3.6
OBUS NELSON
10,000 +0.4%
9.96
US$99,600 		10,000 +0.4% 9.96 US$99,600
2019-10-09 2019-10-07 B Purchase
3.6
OBUS NELSON
8,000 +0.3%
10.14
US$81,120 		8,000 +0.3% 10.14 US$81,120
2019-10-08 2019-10-04 B Purchase
3.6
OBUS NELSON
7,000 +0.2%
10.40
US$72,800 		7,000 +0.2% 10.40 US$72,800
2019-08-06 2019-08-05 B Purchase OBUS NELSON Non-Executive Director
10,000 +0.4%
10.50
US$105,000 		10,000 +0.4% 10.50 US$105,000
2019-08-05 2019-08-02 B Purchase OBUS NELSON Non-Executive Director
20,000 +0.7%
10.72
US$214,400 		20,000 +0.7% 10.72 US$214,400
2019-04-11 2019-04-10 B Purchase
3.6
OBUS NELSON
30,000 +1.1%
10.33
US$309,900 		30,000 +1.1% 10.33 US$309,900
2019-04-10 2019-04-09 B Purchase
3.6
OBUS NELSON
10,000 +0.4%
10.24
US$102,400 		10,000 +0.4% 10.24 US$102,400
2019-04-10 2019-04-08 B Purchase
3.6
OBUS NELSON
20,000 +0.7%
10.38
US$207,600 		20,000 +0.7% 10.38 US$207,600
2019-02-11 2019-02-08 B Purchase
3.6
OBUS NELSON
Non-Executive Director
5,000 +0.2%
12.15
US$60,750 		5,000 +0.2% 12.15 US$60,750
2019-02-11 2019-02-07 B Purchase
3.6
OBUS NELSON
Non-Executive Director
7,900 +0.3%
12.10
US$95,590 		7,900 +0.3% 12.10 US$95,590
2019-02-06 2019-02-06 B Purchase
3.6
OBUS NELSON
Non-Executive Director
20,000 +0.7%
12.38
US$247,600 		20,000 +0.7% 12.38 US$247,600
2019-01-14 2019-01-11 B Purchase
2.1
Powell Andrew Kenneth William
Non-Executive Director
525 +110.5%
11.62
US$6,100 		525 +110.5% 11.62 US$6,100
2019-01-14 2019-01-10 B Purchase
3.6
OBUS NELSON
Non-Executive Director
20,000 +0.7%
11.33
US$226,600 		20,000 +0.7% 11.33 US$226,600
2019-01-11 2019-01-10 B Purchase
3.2
Sohn Catherine A.
Non-Executive Director
1,000 +4.2%
11.23
US$11,230 		1,000 +4.2% 11.23 US$11,230
2019-06-03 2019-01-08 B Purchase
1.6
Carosella Deborah D
4,500 +52.8%
11.34
US$51,030 		4,500 +52.8% 11.34 US$51,030
2019-01-10 2019-01-08 B Purchase
1.6
GOLDBY STEVEN D
Non-Executive Director
20,000 +43.0%
11.24
US$224,800 		20,000 +43.0% 11.24 US$224,800
2019-01-09 2019-01-08 B Purchase
1.6
SKINNER GREGORY S

Chief Financial Officer

Officer
25,000 +9.5%
11.25
US$281,250 		25,000 +9.5% 11.25 US$281,250
Explore more

More insider trading research around Lifecore Biomedical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America